Sorrento Therapeutics (SRNE) Announces Its Oral SARS-CoV-2 Main Protease (Mpro) Inhibitor, STI-1558, Strongly Neutralizes Omicron
Go back to Sorrento Therapeutics (SRNE) Announces Its Oral SARS-CoV-2 Main Protease (Mpro) Inhibitor, STI-1558, Strongly Neutralizes Omicron| SORRENTO THERAPEUT (NASDAQ: SRNE) | Delayed: 0.31 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.31 | 52 Week High | $10.26 | |||
| Open | $0.31 | 52 Week Low | $4.25 | |||
| Day High | $0.31 | P/E | N/A | |||
| Day Low | $0.31 | EPS | $-0.50 | |||
| Volume | 97,454 | |||||
